TP53 and head and neck squamous cell carcinoma: [25] On the contrary, in head and neck squamous cell carcinoma (HNSC), TP53 mutations are associated with inhibitory immune features such as lower lymphocyte infiltration signature score and lower CD8 cell signature score, which was also reported in previous studies.